Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2023.1121500
Abstract: Introduction Alzheimer’s disease (AD) is indicated by a decrease in amyloid beta 42 (Aβ42) level or the Aβ42/Aβ40 ratio, and by increased levels of Tau with phosphorylated threonine at position 181 (pTau181) in cerebrospinal fluid…
read more here.
Keywords:
non demented;
two independent;
independent cohorts;
atrophy ... See more keywords